Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice

doi 10.5772/53031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech